| Cat. No. |
Name |
CAS No. |
Description |
|
KI0107 |
Su11274 |
658084-23-2 |
Su11274 is a ATP-competitive c-Met specific inhibitor....
|
|
KI2718 |
SU14813 |
627908-92-3 |
SU14813 is a novel multiple receptor tyrosine kinase inhibitor....
|
|
KI4773 |
SU5416 |
204005-46-9 |
....
|
|
KI0234 |
Sunitinib |
557795-19-4 |
Sunitinib is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR) -1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-α and β, Flt3 (Fms-like tyrosyl kinase-3), Ret, and Kit....
|
|
KI1270 |
TAE684 |
761439-42-3 |
TAE684 is a potent ALK inhibitor with an IC50 of 3 nM....
|
|
KI2104 |
TCS 401 |
243967-42-2 |
TCS 401 is a selective inhibitor of protein-tyrosine phosphatase 1B (PTP1B) with a Ki value of 290 nM....
|
|
KI1113 |
Telatinib |
332012-40-5 |
Telatinib is an orally available, small-molecule multitargeted vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases inhibitor....
|
|
KI1173 |
TG101209 |
936091-14-4 |
TG101209 potently inhibits JAK2, FLT3 and RET kinases with IC50 values of 6, 25 and 17 nM, respectively....
|
|
KI1124 |
TG101348 |
936091-26-8 |
TG101348 is a selective small-molecule inhibitor of JAK2....
|
|
KI0078 |
Tivozanib |
475108-18-0 |
Tivozanib is a highly potent inhibitor of vascular endothelial growth factor receptor (VEGFR) tyrosine kinases....
|
|
KI2840 |
TKI-258 |
405169-16-6 |
TKI-258 is a novel and multitargeted receptor tyrosine kinase (RTK) inhibitor....
|
|
KI0273 |
Tofacitinib citrate |
540737-29-9 |
Tofacitinib citrate is a PAN-JAK inhibitor with phenomenal selectivity against the human kinome....
|
|
KI4054 |
Torcetrapib |
262352-17-0 |
....
|
|
KI3315 |
TSU-68 (SU6668) |
252916-29-3 |
TSU-68 is an ATP-competitive and highly potent PDGFR inhibitor....
|
|
KI4009 |
TTNPB |
71441-28-6 |
....
|
|
KI6118 |
Tyrphostin 9 |
10537-47-0 |
....
|
|
KI6070 |
UNC0064-12 |
1430089-64-7 |
....
|
|
KI0284 |
Vandetanib |
443913-73-3 |
Vandetanib is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR)....
|
|
KI1499 |
Varlitinib |
845272-21-1 |
Varlitinib is a reversible, ATP-competitive inhibitor with nanomolar potency in both in vitro and in cell-based assays showing strong activity against EGFR, ErbB2 and ErbB4....
|
|
KI4874 |
Vatalanib Dihydrochloride |
212141-51-0 |
....
|
